AU2003304316A1 - Compounds and methods for the treatment and prevention of bacterial infection - Google Patents

Compounds and methods for the treatment and prevention of bacterial infection

Info

Publication number
AU2003304316A1
AU2003304316A1 AU2003304316A AU2003304316A AU2003304316A1 AU 2003304316 A1 AU2003304316 A1 AU 2003304316A1 AU 2003304316 A AU2003304316 A AU 2003304316A AU 2003304316 A AU2003304316 A AU 2003304316A AU 2003304316 A1 AU2003304316 A1 AU 2003304316A1
Authority
AU
Australia
Prior art keywords
prevention
compounds
treatment
methods
bacterial infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003304316A
Other versions
AU2003304316A8 (en
Inventor
Jimmy D. Ballard
R. John Collier
Michael Mourez
Rodney Tweten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
University of Oklahoma
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of AU2003304316A8 publication Critical patent/AU2003304316A8/en
Publication of AU2003304316A1 publication Critical patent/AU2003304316A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003304316A 2002-11-08 2003-11-10 Compounds and methods for the treatment and prevention of bacterial infection Abandoned AU2003304316A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42498702P 2002-11-08 2002-11-08
US60/424,987 2002-11-08
PCT/US2003/035733 WO2005004791A2 (en) 2002-11-08 2003-11-10 Compounds and methods for the treatment and prevention of bacterial infection

Publications (2)

Publication Number Publication Date
AU2003304316A8 AU2003304316A8 (en) 2005-01-28
AU2003304316A1 true AU2003304316A1 (en) 2005-01-28

Family

ID=34061810

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003304316A Abandoned AU2003304316A1 (en) 2002-11-08 2003-11-10 Compounds and methods for the treatment and prevention of bacterial infection

Country Status (2)

Country Link
AU (1) AU2003304316A1 (en)
WO (1) WO2005004791A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
BE1022949B1 (en) * 2014-06-25 2016-10-21 Glaxosmithkline Biologicals S.A. IMMUNOGENIC COMPOSITION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
AU2771099A (en) * 1998-02-18 1999-09-06 President And Fellows Of Harvard College Inhibition of toxin translocation
MXPA02010826A (en) * 2000-05-04 2006-03-09 Harvard College Compounds and methods for the treatment and prevention of bacterial infection.

Also Published As

Publication number Publication date
WO2005004791A2 (en) 2005-01-20
AU2003304316A8 (en) 2005-01-28
WO2005004791A3 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
EP1594444A3 (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2003209851A1 (en) Method of treatment and/or prophylaxis
HUE041133T2 (en) Methods of administering dalbavancin for treatment of bacterial infections
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
AU2003260778A1 (en) Treatment of pipes
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
AU2003261782A1 (en) Bacteriophages and remedies for bacterial infection
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals
AU2003258176A1 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003304316A1 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2003303948A1 (en) Compositions and methods for preventing infection
AU2003275069A1 (en) Compositions and methods for preventing infection
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2002951913A0 (en) Method of treatment
AU2003258177A1 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2003274359A1 (en) Treatment of fluids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 19, NO 10, PAGE(S) 629 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME PRESIDENT AND FELLOWS OF HARVARD COLLEGE, APPLICATION NO. 2003304316, UNDER INID (71) CORRECT THE NAME TO READ THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA; PRESIDENT AND FELLOWS OF HARVARD COLLEGE